Komori
M&A Capital Partners (6080) · RiskMitigated

Dependence on completed transactions in the dispensing pharmacy sector

First written in FY2016. 3 of 6 entries say "Mitigated", first in FY2017. Latest entry: FY2019-Q3.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016MitigatedFY2017 – FY20182016: 12017: 120172018: 120182019: 32019
Same theme, other companies
Dependence on the project mix in specific sectorsA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2019-Q3MitigatedAnnual report

    「As a result, the group’s operating results improved, with completed transactions increasing steadily without concentration in any particular industry. Revenue increased by ¥3,549,352 thousand, or 55.7%, year on year to ¥9,916,487 thousand.」

    The company explains that completed transactions increased steadily without concentration in any particular industry, indicating that dependence on the dispensing pharmacy industry declined relatively.
  2. FY2019-Q2RestatedAnnual report

    「Although the company itself was affected by factors such as the stabilization of consolidation in the dispensing pharmacy industry, the number of transactions increased because other business succession transactions performed well.」

    The stabilization of consolidation in the dispensing pharmacy industry continues to reduce the number of completed transactions, but the company’s standalone number of completed transactions increased because other business succession transactions performed well.
  3. FY2019-Q1MaterialisedAnnual report

    「This was also attributable to a decline in transactions involving dispensing pharmacies, which had traditionally contributed to the number of completed transactions, as industry consolidation has stabilized.」

    The company explains that transactions that had traditionally contributed to the number of completed transactions actually declined as consolidation in the dispensing pharmacy industry stabilized.
  4. FY2018MitigatedAnnual report

    「Completed M&A transactions in the dispensing pharmacy industry accounted for approximately 30% of the total in the most recent period.」

    Dependence on completed transactions in the dispensing pharmacy industry declined from approximately 40% previously to approximately 30%. However, the risk of declining demand due to institutional reforms and other changes remains.
  5. FY2017MitigatedAnnual report

    「Completed M&A transactions in the dispensing pharmacy industry accounted for approximately 40% of the total in the most recent period.」

    Dependence on completed transactions in the dispensing pharmacy industry declined from “nearly half of the total” previously to “approximately 40%.” However, the risk of declining demand due to institutional reforms and other changes in the industry remains.
  6. FY2016First statedAnnual report

    「The number of completed M&A transactions in the dispensing pharmacy industry accounted for nearly half of the total in the most recent period」

    The company states that completed transactions in the dispensing pharmacy industry account for nearly half of the total in the most recent period, identifying a decline in demand resulting from institutional reforms and other changes in the industry as a risk.
Moved together

"Increase in Completed M&A Deals and Large-Scale Transactions" moved the same way as this thread, in the same document, in 3 of its 6 moves.

33222★12345
  1. ★This thread
  2. 1Increase in Completed M&A Deals and Large-Scale Transactions3×
  3. 2Expanding the Sales Division Through Consultant Hiring3×
  4. 3Customer Acquisition Combining Inbound and Outbound Sales2×
  5. 4Dilution of Per-Share Value Due to Stock Option Exercise2×
  6. 5Recovery of the Domestic M&A Market and Diversification of Buyer and Divestment Needs2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
M&A Capital Partners's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Dependence on completed transactions in the dispensing pharmacy sector | M&A Capital Partners Co.,Ltd. (6080) | Komori